Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2008 / Article

Review | Open Access

Volume 5 |Article ID 651379 | https://doi.org/10.1093/ecam/nem074

A. R. Carmichael, "Can Vitex Agnus castus Be Used for the Treatment of Mastalgia? What Is the Current Evidence?", Evidence-Based Complementary and Alternative Medicine, vol. 5, Article ID 651379, 4 pages, 2008. https://doi.org/10.1093/ecam/nem074

Can Vitex Agnus castus Be Used for the Treatment of Mastalgia? What Is the Current Evidence?

Received27 Apr 2006
Accepted18 May 2007

Abstract

There have been many treatments suggested for the management of mastalgia; one of these is the fruit extract of Vitex Agnus castus L. commonly known as Agnus castus, an extract of a deciduous shrub native to Mediterranean Europe and Central Asia. It is postulated that A. castus suppresses the stress-induced latent hyperprolactinemia which is a release of supra-physiological levels of prolactin in some patients in response to stressful stimuli. It is postulated that A. castus could be effective in the treatment of cyclical mastalgia by inhibiting the release of excess prolactin by blocking Dopamine-2 receptor type on pituitary. The adverse events following A. castus treatment are mild and reversible. The aim of this review is assess the efficacy of A. castus in the treatment of mastalgia. Data from randomized and non-randomized studies regarding the efficacy and safety of A. castus is reviewed in a systematic fashion. It is concluded that A. castus can be considered as an efficient alternative phytotherapeutic agent in the treatment of mastalgia.

Copyright © 2008 A. R. Carmichael. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

750 Views | 1012 Downloads | 26 Citations
 PDF Download Citation Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.